Roberts Glore & CO Inc Charles River Laboratories International, Inc. Transaction History
Roberts Glore & CO Inc
- $328 Million
- Q2 2024
A detailed history of Roberts Glore & CO Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Roberts Glore & CO Inc holds 5,401 shares of CRL stock, worth $1.02 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
5,401
Previous 5,406
0.09%
Holding current value
$1.02 Million
Previous $1.46 Million
23.84%
% of portfolio
0.34%
Previous 0.44%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
714Shares Held
51.7MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$960 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$394 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$360 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$332 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.6B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...